Combination chemotherapy of malignant glioma. Effect of postoperative treatment with CCNU, vincristine, amethopterine and procarbazine (Q40203570)

18 September 2017

title

Combination chemotherapy of malignant glioma. Effect of postoperative treatment with CCNU, vincristine, amethopterine and procarbazine (English)

1 reference

https://api.crossref.org/works/10.1016/0014-2964(78)90225-6

2 June 2022

author name string

W. D. Heiss

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A216554

2 June 2022

M. Turnheim

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A216554

2 June 2022

B. Mamoli

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A216554

2 June 2022

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=216554

2 June 2022

publication date

1 November 1978

1 reference

full work available at URL

18 September 2017

https://api.elsevier.com/content/article/PII:0014296478902256?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/0014-2964(78)90225-6

https://api.elsevier.com/content/article/PII:0014296478902256?httpAccept=text/plain

2 June 2022

1 reference

https://api.crossref.org/works/10.1016/0014-2964(78)90225-6

European Journal of Cancer

2 June 2022

published in

1 reference

18 September 2017

volume

14

1 reference

18 September 2017

issue

11

1 reference

18 September 2017

page(s)

1191-1202

1 reference

Adjuvant nitrosourea therapy for glioblastoma

18 September 2017

cites work

2

1 reference

https://api.crossref.org/works/10.1016/0014-2964(78)90225-6

Glioblastoma multiforme; review of 219 cases with regard to natural history, pathology, diagnostic methods, and treatment

2 June 2022

3

1 reference

https://api.crossref.org/works/10.1016/0014-2964(78)90225-6

Glioblastoma multiforme: its treatment and some factors effecting survival

2 June 2022

4

1 reference

https://api.crossref.org/works/10.1016/0014-2964(78)90225-6

Glioblastoma multiforme. An analysis of the results of postoperative radiotherapy alone versus radiotherapy and concomitant 5-fluorouracil. (A prospective randomized study of 32 cases)

2 June 2022

5

1 reference

https://api.crossref.org/works/10.1016/0014-2964(78)90225-6

Treatment of malignant glioma. A controlled study of chemotherapy and irradiation

2 June 2022

6

1 reference

https://api.crossref.org/works/10.1016/0014-2964(78)90225-6

Controlled study of CCNU and radiation therapy in malignant astrocytoma

2 June 2022

7

1 reference

https://api.crossref.org/works/10.1016/0014-2964(78)90225-6

SENSITIVITY OF INTRACRANIAL GLIOMAS TO VINCRISTINE SULPHATE

2 June 2022

10

1 reference

https://api.crossref.org/works/10.1016/0014-2964(78)90225-6

Chloroethyl-cyclohexyl-nitrosourea (CCNU) in the treatment of malignant brain tumors

2 June 2022

14

1 reference

https://api.crossref.org/works/10.1016/0014-2964(78)90225-6

Procarbazine hydrochloride in the treatment of brain tumors. Phase 2 study

2 June 2022

15

1 reference

https://api.crossref.org/works/10.1016/0014-2964(78)90225-6

Chemotherapy in the treatment of malignant brain tumors

2 June 2022

16

1 reference

https://api.crossref.org/works/10.1016/0014-2964(78)90225-6

Combination chemotherapy with 1-(2-chloroethyl-3-cyclohexyl-1-nitrosourea) (CCNU), vincristine and methotrexate in primary and metastatic brain tumors—A preliminary report

2 June 2022

18

1 reference

https://api.crossref.org/works/10.1016/0014-2964(78)90225-6

Phase II study of procarbazine, CCNU, and vincristine combination chemotherapy in the treatment of malignant brain tumors

2 June 2022

19

1 reference

https://api.crossref.org/works/10.1016/0014-2964(78)90225-6

Chemotherapy of brain tumors

2 June 2022

21

1 reference

https://api.crossref.org/works/10.1016/0014-2964(78)90225-6

Permeability Characteristics of Brain Adjacent to Tumors in Rats

2 June 2022

23

1 reference

https://api.crossref.org/works/10.1016/0014-2964(78)90225-6

Chemotherapy of brain tumors

2 June 2022

24

1 reference

https://api.crossref.org/works/10.1016/0014-2964(78)90225-6

INTRA-ARTERIAL VINCRISTINE THERAPY OF PRIMARY GLIOMAS

2 June 2022

30

1 reference

https://api.crossref.org/works/10.1016/0014-2964(78)90225-6

The neuromyopathy of vincristine in man. Clinical, electrophysiological and pathological studies

2 June 2022

32

1 reference

https://api.crossref.org/works/10.1016/0014-2964(78)90225-6

Chemotherapy of cerebral gliomas with intra-carotid methotrexate-infusion.

2 June 2022

36

1 reference

https://api.crossref.org/works/10.1016/0014-2964(78)90225-6

Brain tumor chemotherapy with intrathecal methotrexate

2 June 2022

37

1 reference

https://api.crossref.org/works/10.1016/0014-2964(78)90225-6

Cerebrospinal fluid perfusion for central nervous system neoplasms

2 June 2022

38

1 reference

https://api.crossref.org/works/10.1016/0014-2964(78)90225-6

Individual Comparisons by Ranking Methods

2 June 2022

42

1 reference

https://api.crossref.org/works/10.1016/0014-2964(78)90225-6

A generalized Wilcoxon test for comparing arbitrarily singly-censored samples

2 June 2022

43

1 reference

https://api.crossref.org/works/10.1016/0014-2964(78)90225-6

Editorial: Cancer research-controversy, progress and prospects

2 June 2022

44

1 reference

https://api.crossref.org/works/10.1016/0014-2964(78)90225-6

Acute lymphoblastic leukemia in adults and children. Differences in response with similar therapeutic regimens

2 June 2022

45

1 reference

https://api.crossref.org/works/10.1016/0014-2964(78)90225-6

Chemotherapeutic implications of growth fraction and cell cycle time in glioblastomas

2 June 2022

46

1 reference

https://api.crossref.org/works/10.1016/0014-2964(78)90225-6

Criteria for evaluating patients undergoing chemotherapy for malignant brain tumors

2 June 2022

48

1 reference

https://api.crossref.org/works/10.1016/0014-2964(78)90225-6

Treatment of malignant astrocytomas

2 June 2022

51

1 reference

https://api.crossref.org/works/10.1016/0014-2964(78)90225-6

Computed Tomography in the Evaluation of Malignant Glioma Before and After Therapy

2 June 2022

53

1 reference

https://api.crossref.org/works/10.1016/0014-2964(78)90225-6

Vinca alkaloid neuropathy: nerve biopsy studies in rats and in man.

2 June 2022

Vincristine neuropathy: an electrophysiological and histological study

54

0 references

55

1 reference

https://api.crossref.org/works/10.1016/0014-2964(78)90225-6

Vincristine neuropathy. Clinical and electrophysiological observations

2 June 2022

56

1 reference

https://api.crossref.org/works/10.1016/0014-2964(78)90225-6

Retention of tritiated methotrexate in a transplantable mouse glioma

2 June 2022

35

1 reference

https://api.crossref.org/works/10.1016/0014-2964(78)90225-6

13 January 2023

Identifiers

1 reference

18 September 2017

1 reference